Resources Contact Us Home
Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use

Image Number 12 for United States Patent #5609869.

Hybrid immunoglobulin-enzyme molecules are provided which are composed of antibodies, or derivatives or fragments thereof, which specifically bind an arterial or venous thrombus that are operably linked to the enzymatically active portions of thrombolytic enzymes such as plasminogen activators. In a preferred embodiment the hybrid molecules specifically bind to fibrin and have fibrinolytic activity. The hybrid molecules of the present invention may be produced by any means, including chemical conjugation, or by means of recombinant DNA, genetic engineering and/or hybridoma technology. Methods for making and using the molecules in diagnosis and therapy are also disclosed.

  Recently Added Patents
Packaging for socks
Network based JIT on a priori knowledge of a set of disparate clients
Multiplanar image displays and media formatted to provide 3D imagery without 3D glasses
Semiconductor device
Method of predicting a motion vector for a current block in a current picture
Laboratory spatula
Image forming system, printing control method, and program
  Randomly Featured Patents
Focussed light source pointer for three dimensional display
Children's computer keyboard
Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection
Method for stripping a wafer from a carrier
Method of programming a flash memory cell
Method and system for determining network capacity to implement voice over IP communications
Shuffleboard table
Ultrasound transducer featuring a pitch independent interposer and method of making the same
Electromechanical momentary-contact switch having timed supplementary functions
Low inertia frame for detecting coriolis acceleration